Learn more at LeadIQ.com

Insights

Gathering insights about Cabaletta Bio…

Similar companies to Cabaletta Bio

Cabaletta Bio Tech Stack

Cabaletta Bio uses 8 technology products and services including NetSuite, jQuery, Cisco, and more. Explore Cabaletta Bio's tech stack below.

NetSuite
E-commerce
jQuery
Javascript Libraries
Cisco
Network Hardware
PHP
Programming Languages
Linux
Programming Languages
Yoast SEO
Search Engines
Adobe Creative Suite
Visualisation Software
Nginx
Web Servers

Media & News

Cabaletta Bio partnered with Lonza on Jul 1st '24.
In July, Cabaletta Bio (NASDAQ:CABA) entered into a new manufacturing agreement with Lonza, an industry-leading contract development and manufacturing organization (CDMO) that provides comprehensive, fully integrated drug development and manufacturing solutions and services to biotechnology and pharmaceutical companies.
Sep 10, 2024 | swissco.com
Cabaletta Bio hires Yuan as Chief Technology Officer.
Cabaletta Bio welcomes sarah Yuan, phd, as new Chief Technology Officer.
Aug 21, 2024 | biobuzz.io
Cabaletta Bio hires Sarah Yuan as Chief Technology Officer.
Cabaletta Bio is excited to announce the appointment of Dr. Sarah Yuan as the new Chief Technology Officer.
Aug 21, 2024 | biobuzz.io
Swiss National Bank invests into Cabaletta Bio $930K.
Swiss National Bank invests $930,000 in Cabaletta Bio, Inc. (NASDAQ:CABA).
Feb 29, 2024 | www.marketbeat.com
Cabaletta Bio is developing chimeric antigen receptor T cell therapies for autoimmune diseases.
Cabaletta Bio is recognized for its work in developing chimeric antigen receptor T cell (CART) therapies for autoimmune diseases.
Feb 04, 2024 | www.investing.com
Cabaletta Bio is developing CAR T-cell therapy.
Cabaletta Bio developing CAR T-cell therapy for other autoimmune conditions
Jan 09, 2024 | sclerodermanews.com
Cabaletta Bio recognized as FDA Fast Track Designations for CABA-201.
Cabaletta Bio receives additional FDA Fast Track Designations for CABA-201 in dermatomyositis...
Jan 07, 2024 | www.wdrb.com

Cabaletta Bio's Email Address Formats

Cabaletta Bio uses at least 1 format(s):

Cabaletta Bio Email Formats	Example	Percentage
First.Last@cabalettabio.com	John.Doe@cabalettabio.com	90%
FirstLast@cabalettabio.com	JohnDoe@cabalettabio.com	6%
First@cabalettabio.com	John@cabalettabio.com	3%
First.MiddleLast@cabalettabio.com	John.MichaelDoe@cabalettabio.com	1%

Frequently Asked Questions

Where is Cabaletta Bio's headquarters located?

Cabaletta Bio's main headquarters is located at 2929 Arch St Suite 600 Philadelphia, Pennsylvania 19104 US. The company has employees across 2 continents, including North AmericaEurope.

What is Cabaletta Bio's stock symbol?

Cabaletta Bio is a publicly traded company; the company's stock symbol is CABA.

What is Cabaletta Bio's official website and social media links?

Cabaletta Bio's official website is cabalettabio.com and has social profiles on LinkedIn.

How much revenue does Cabaletta Bio generate?

As of November 2024, Cabaletta Bio's annual revenue reached $35M.

What is Cabaletta Bio's SIC code NAICS code?

Cabaletta Bio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cabaletta Bio have currently?

As of November 2024, Cabaletta Bio has approximately 169 employees across 2 continents, including North AmericaEurope. Key team members include Chief Technology Officer: S. Y.Chief Business Officer: A. D.Chief Compliance Officer: H. H.. Explore Cabaletta Bio's employee directory with LeadIQ.

What industry does Cabaletta Bio belong to?

Cabaletta Bio operates in the Biotechnology Research industry.

What technology does Cabaletta Bio use?

Cabaletta Bio's tech stack includes NetSuitejQueryCiscoPHPLinuxYoast SEOAdobe Creative SuiteNginx.

What is Cabaletta Bio's email format?

Cabaletta Bio's email format typically follows the pattern of . Find more Cabaletta Bio email formats with LeadIQ.

How much funding has Cabaletta Bio raised to date?

As of November 2024, Cabaletta Bio has raised $87M in funding. The last funding round occurred on May 17, 2023 for $87M.

When was Cabaletta Bio founded?

Cabaletta Bio was founded in 2017.

Cabaletta Bio

Cabaletta Bio

Biotechnology ResearchPennsylvania, United States51-200 Employees

Cabaletta Bio (Nasdaq: CABA) is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies that have the potential to provide a deep and durable, perhaps curative, treatment for patients with autoimmune diseases. The CABA™ platform encompasses two strategies: the CARTA (chimeric antigen receptor T cells for autoimmunity) strategy, with CABA-201, a 4-1BB-containing fully human CD19-CAR T, as the lead product candidate being evaluated in systemic lupus erythematosus and myositis, and the CAART (chimeric autoantibody receptor T cells) strategy, with multiple clinical-stage candidates, including DSG3-CAART for mucosal pemphigus vulgaris and MuSK-CAART for MuSK myasthenia gravis. The expanding CABA™ platform is designed to develop potentially curative therapies that offer deep and durable responses for patients with a broad range of autoimmune diseases. Cabaletta Bio’s headquarters and labs are located in Philadelphia, PA.

Company Overview

Headquarters: 2929 Arch St Suite 600 Philadelphia, Pennsylvania 19104 US
Website: cabalettabio.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: CABA
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2017
Employees: 51-200

Media & News

Funding & Financials

$87M
Cabaletta Bio has raised a total of $87M of funding over 5 rounds. Their latest funding round was raised on May 17, 2023 in the amount of $87M.
$10M$50M
Cabaletta Bio's revenue is in the range of $10M$50M

Funding & Financials

$87M
Cabaletta Bio has raised a total of $87M of funding over 5 rounds. Their latest funding round was raised on May 17, 2023 in the amount of $87M.
$10M$50M
Cabaletta Bio's revenue is in the range of $10M$50M

Company Leadership

S. Y.
Chief Technology Officer
✕
Access Insights for Cabaletta Bio and Millions of Other Companies
Sign up for full access to Cabaletta Bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Cabaletta Bio and Millions of Other Companies
Sign up for full access to Cabaletta Bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. D.
Chief Business Officer
✕
Access Insights for Cabaletta Bio and Millions of Other Companies
Sign up for full access to Cabaletta Bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Cabaletta Bio and Millions of Other Companies
Sign up for full access to Cabaletta Bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
H. H.
Chief Compliance Officer
✕
Access Insights for Cabaletta Bio and Millions of Other Companies
Sign up for full access to Cabaletta Bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Cabaletta Bio and Millions of Other Companies
Sign up for full access to Cabaletta Bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. M.
Chief Financial Officer
✕
Access Insights for Cabaletta Bio and Millions of Other Companies
Sign up for full access to Cabaletta Bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Cabaletta Bio and Millions of Other Companies
Sign up for full access to Cabaletta Bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. B.
Chief Scientific Officer
✕
Access Insights for Cabaletta Bio and Millions of Other Companies
Sign up for full access to Cabaletta Bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Cabaletta Bio and Millions of Other Companies
Sign up for full access to Cabaletta Bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

A. M.
Chief Financial Officer
✕
Access Insights for Cabaletta Bio and Millions of Other Companies
Sign up for full access to Cabaletta Bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Cabaletta Bio and Millions of Other Companies
Sign up for full access to Cabaletta Bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. M.
Co-Founder
✕
Access Insights for Cabaletta Bio and Millions of Other Companies
Sign up for full access to Cabaletta Bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Cabaletta Bio and Millions of Other Companies
Sign up for full access to Cabaletta Bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. B.
Chief Scientific Officer
✕
Access Insights for Cabaletta Bio and Millions of Other Companies
Sign up for full access to Cabaletta Bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Cabaletta Bio and Millions of Other Companies
Sign up for full access to Cabaletta Bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. J. C.
Chief Medical Officer
✕
Access Insights for Cabaletta Bio and Millions of Other Companies
Sign up for full access to Cabaletta Bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Cabaletta Bio and Millions of Other Companies
Sign up for full access to Cabaletta Bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. P.
Co-Founder, Co-Chair Scientific Advisory Board
✕
Access Insights for Cabaletta Bio and Millions of Other Companies
Sign up for full access to Cabaletta Bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Cabaletta Bio and Millions of Other Companies
Sign up for full access to Cabaletta Bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.